Skip to content
Research Article Open access CC BY 4.0

Transcription Factor 7 Like 2 (TCF7L2) Expression Level Variation Contributes to VEGF Alteration in Diabetic Retinopathy

Mahmood Hassan Dalhat, Maimuna Musa

Ophthalmology Research: An International Journal · pp. 1–7 · Published 9 Jan 2018

10.9734/OR/2018/38734

Abstract

Diabetic retinopathy (DR) is a multifactorial disease which causes blindness among people with Diabetes worldwide. It has complex pathophysiology linked to various genetic variations. TCF7L2 (Transcription factor 7 like 2) is among the most important candidate genes which play a major role in hyperglycemia and neovascularization. Neovascularization is a clinical symptom of DR associated with upregulation of vascular endothelial growth factor (VEGF) as established by numerous published articles. The purpose of this review is to highlight the role of TCF7L2 polymorphism in the development of DR via alteration in VEGF expression level. We used available published data to explain the association of TCF7L2 polymorphism with DR. We concluded that genetic studies reports revealed TCF7L2 polymorphism might be associated with DR development.  

DM DR NPDR PDR TCF7L2 Wnt VEGF polymorphism

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.